NCT02044718

Brief Summary

An adverse event (AE) is defined as unintended injury or complication, which results in disability, death or prolongation of hospital stay, and is caused by healthcare management (including omissions) rather than the patient's disease. Retrospective record reviews in several countries have shown that 2,9% to 16,6% of patients in acute hospitals experience one or more AEs. A patient with an AE may require a higher level of care. Although all AEs are important, preventable AEs that result in an upgraded level of patient care are of particular concern. In this study it's defined as an unplanned admission to intensive care unit (ICU) or a Mobile Emergency Team (MET) intervention. The objectives of this study are to determine the incidence of (preventable) adverse events requiring ICU admission or MET intervention and to assess the level of harm of each AE.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
878

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 24, 2014

Completed
Last Updated

January 24, 2014

Status Verified

January 1, 2014

Enrollment Period

1.6 years

First QC Date

December 19, 2013

Last Update Submit

January 22, 2014

Conditions

Keywords

adverse eventsunplanned admission intensive carechart review

Outcome Measures

Primary Outcomes (2)

  • Incidence of adverse events requiring a higher level of care

    An adverse event is an unintended injury or complication, which results in disability at discharge, death or prolongation of hospital stay, and is caused by healthcare management (including omissions) rather than the patient's disease. (Wilson, 1995)

    6 months

  • The number of participants with preventable adverse events

    Assess the preventability of these adverse events using six point scale with a range of not preventable until totally preventable

    6 months

Secondary Outcomes (3)

  • Type adverse events

    6 months

  • Clinical impact of adverse events in terms of outcome

    6 months

  • Quality of the chart review

    6 months

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

primary care clinic

You may qualify if:

  • All patients being transferred to a higher level of care during the study period (November 2011 - May 2012)
  • In practice, the higher level of care means
  • (1) (re)admission to the Intensive Care Unit from other care units in the hospital providing lower intensity care,
  • (2) to an intervention by a Medical Emergency Team due to an unanticipated change in the patient's clinical status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasselt University

Hasselt, Limburg, 3500, Belgium

Location

MeSH Terms

Conditions

SepsisNeoplasmsMyocardial InfarctionHeart FailureWounds and InjuriesDiabetes MellitusLung Diseases

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaNecrosisGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesRespiratory Tract Diseases

Study Officials

  • Kristel Marquet, drs

    Hasselt University

    PRINCIPAL INVESTIGATOR
  • Arthur Vleugels, prof. dr.

    KU Leuven

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof. dr.

Study Record Dates

First Submitted

December 19, 2013

First Posted

January 24, 2014

Study Start

November 1, 2011

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

January 24, 2014

Record last verified: 2014-01

Locations